Boulder-based oncology company Enliven Therapeutics raises $55M Series A
BOULDER — Enliven Therapeutics Inc., a Boulder-based cancer-drug developer, is exiting from stealth operations by announcing that it raised $55 […]
Source: BizWest
Check out market updates
BOULDER — Enliven Therapeutics Inc., a Boulder-based cancer-drug developer, is exiting from stealth operations by announcing that it raised $55 […]
Source: BizWest